Insulin, Glargine SUSTAGLAR
| Product Overview | |
| Generic Name | Insulin, Glargine SUSTAGLAR |
| Brand Name(s) | Sustaglar |
| Form | Solution for inj (vial, pre‑filled syringes) |
| Strength | 100 IU/mL |
| Therapeutic Class | Antidiabetic agent; long‑acting insulin analogue |
| ATC Code | A10AE04 |
| Manufacturing & Regulatory | |
| Manufacturer | Regenix Biosciences LTD. |
| Country | India, Mexico |
| GMP Compliance | WHO-GMP |
| COFEPRIS | Pending |
| Free Sale Certificate | Available per batch upon request |
| Logistics & Export | |
| MOQ | 5k |
| Shelf Life | 36 months |
| Storage | 2–8 °C, protect from light |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon request |
Description
Glargine type Biosimilar insulin
